Aquilon Pharma Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.95M
- Investors
-
4
Aquilon Pharma General Information
Description
Developer of pharmaceutical drugs designed to offer the treatment of pulmonary diseases. The company focuses on developing drugs for the treatment of respiratory disorders and enhances both the lung deposition and the pharmacology of existing drugs for asthma and chronic obstructive pulmonary disease, enabling patients to get efficient inhalation drugs for respiratory problems.
Contact Information
Website
www.aquilonpharma.comCorporate Office
- 59 Quai de la Boverie
- Walloon Region
- 4020 Liege
- Belgium
Corporate Office
- 59 Quai de la Boverie
- Walloon Region
- 4020 Liege
- Belgium
Aquilon Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 23-Dec-2024 | $1.95M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series B) | Cancelled | Generating Revenue | ||||
| 3. Later Stage VC | 12-Dec-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 26-Oct-2015 | $388K | $388K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 14-Nov-2011 | Completed | Generating Revenue |
Aquilon Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| E Shares | ||||||||
| D Shares | ||||||||
| C Shares | ||||||||
| B Shares | ||||||||
| A Shares | ||||||||
| Ordinary | ||||||||
| Ordinary | 31,942 | $48.47 | $48.47 | 1x | $48.47 | 19.25% | ||
| Ordinary | 34,500 | $10.5 | $10.5 | 1x | $10.5 | 20.79% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Aquilon Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aquilon Pharma Patents
Aquilon Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4003320-B1 | Microparticles with golf ball depressions for use in the treatment and prevention of pulmonary diseases | Active | 10-Sep-2019 | ||
| EP-4003320-A1 | Golf ball-like microparticles for use in the treatment and prevention of pulmonary diseases | Active | 10-Sep-2019 | ||
| CA-3150551-A1 | Golf ball-like microparticles for use in the treatment and prevention of pulmonary diseases | Active | 10-Sep-2019 | ||
| ES-2942901-T3 | Microparticles with golf ball-shaped depressions for use in the treatment and prevention of lung diseases | Active | 10-Sep-2019 | ||
| CA-3150551-C | Golf ball-like microparticles for use in the treatment and prevention of pulmonary diseases | Active | 10-Sep-2019 | A61K31/573 |
Aquilon Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aquilon Pharma Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Noshaq | Venture Capital | Minority | ||
| SambrInvest | Venture Capital | Minority | ||
| Scale Investment Funds | Venture Capital | Minority | ||
| Be Angels | Angel Group | Minority |
Aquilon Pharma FAQs
-
When was Aquilon Pharma founded?
Aquilon Pharma was founded in 2011.
-
Where is Aquilon Pharma headquartered?
Aquilon Pharma is headquartered in Liege, Belgium.
-
What is the size of Aquilon Pharma?
Aquilon Pharma has 22 total employees.
-
What industry is Aquilon Pharma in?
Aquilon Pharma’s primary industry is Pharmaceuticals.
-
Is Aquilon Pharma a private or public company?
Aquilon Pharma is a Private company.
-
What is the current valuation of Aquilon Pharma?
The current valuation of Aquilon Pharma is .
-
What is Aquilon Pharma’s current revenue?
The current revenue for Aquilon Pharma is .
-
How much funding has Aquilon Pharma raised over time?
Aquilon Pharma has raised $4.7M.
-
Who are Aquilon Pharma’s investors?
Noshaq, SambrInvest, Scale Investment Funds, and Be Angels have invested in Aquilon Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
